We are live on
!
Find out more
TARO
Taro Pharmaceutical Industries Ltd.
TARO
TARO
Delisted
TARO was delisted on the 21st of June, 2024.
90 hedge funds and large institutions have $205M invested in Taro Pharmaceutical Industries Ltd. in 2023 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 37 increasing their positions, 27 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
160% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 5
37% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 27
11% more capital invested
Capital invested by funds: $185M → $205M (+$20.4M)
10% more funds holding
Funds holding: 82 → 90 (+8)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
90
Holders Change
+8
Holders Change %
+9.76%
% of All Funds
1.31%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
13
Increased
37
Reduced
27
Closed
5
Calls
$20K
Puts
–
Net Calls
+$20K
Net Calls Change
+$20K
Top Buyers
| 1 |
M
Murchinson
Toronto,
Ontario, Canada
|
+$2.36M |
| 2 |
Morgan Stanley
New York
|
+$2.2M |
| 3 |
BlackRock
New York
|
+$1.51M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$477K |
| 5 |
SO
STRS Ohio
Columbus,
Ohio
|
+$383K |
Top Sellers
| 1 |
CAC
Cowen and Company
New York
|
-$2.61M |
| 2 |
Verition Fund Management
Greenwich,
Connecticut
|
-$2.28M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$1.15M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$1.05M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$637K |
